2017 ARVO Annual Meeting, Baltimore, Maryland (US)

2017 ARVO Annual Meeting, Baltimore, Maryland (US)

The company will present several posters on both its lead products and an oral presentation on its GS030 optogenetics product.

– GS010 aiming at treating LHON, a rare mitochondrial genetic disease

Phase I/IIa Visual Acuity Outcomes 1.5-Years Post-Treatment with rAAV2/2-ND4, an Investigational Gene Therapy for ND4 LHON.

Poster session:  Wednesday 10 May, 2017, 11.00am – 12.45pm, Session Low Vision Populations, Services and Treatments, Posterboard #: B0588, Abstract Number: 4681 – B0588

Preliminary Baseline Characteristics of Patients with Leber Hereditary Optic Neuropathy (LHON) Enrolled in the RESCUE and REVERSE Clinical Gene Therapy Trials. 

Poster session: Wednesday 10 May, 2017, 8.30am – 10.15am, Session Optic Neuropathy, Posterboard #: A0036, Abstract Number: 3865 – A0036

– GS030 based on optogenetics to treat RP

Long term visual restoration using optogenetic engineering of retinal ganglion cells with AAV2.7m8- ChrimsonR-tdTomato

Oral presentation:  Tuesday 9 May, 9.15-9.30 am, Session Diseases and Protection, Abstract Number # 1219

Visual acuity and optical flow in primate retinal ganglion cells treated with an optogenetic vision restoration strategy using ChrimsonR

Poster session:  Thursday 11 May, 2017, 11.30am – 1.15pm, Session Visual Disease Models and Restoration, Posterboard # B0475 – Abstract Number: 5883 – B0475

Modeling the dynamics of light-driven microbial opsin ChrimsonR

Poster session:  Thursday 11 May, 2017, 11.30am – 1.15pm, Session Visual Disease Models and Restoration, Posterboard # B0465 – Abstract Number: 5873 – B0465